NeuroDx AI
New York, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $60M
Overview
An AI-driven diagnostics company creating digital biomarkers for neurological and psychiatric conditions.
NeuroscienceAI / Machine LearningDiagnostics
Technology Platform
A machine learning platform that analyzes multimodal clinical data (e.g., speech, motion) to generate objective digital biomarkers for brain disorders.
Funding History
1Total raised:$60M
Series B$60M
Opportunities
Potential to revolutionize disease diagnosis and monitoring with objective, data-driven tools that enable earlier intervention.
Risk Factors
Risk of failing to achieve clinical validation and regulatory approval for its AI algorithms, and challenges in changing established clinical practices.
Competitive Landscape
Part of a crowded and emerging field of AI-based diagnostic companies targeting neurological and psychiatric conditions.